Benefits and guidelines for utilizing blockchain technology in pharmaceutical supply chains: case Bayer Pharmaceuticals

Thumbnail Image

Files

bachelor_Kurki_Jani_2016.pdf (922.36 KB)

URL

Journal Title

Journal ISSN

Volume Title

School of Business | Bachelor's thesis
Unless otherwise stated, all rights belong to the author. You may download, display and print this publication for Your own personal use. Commercial use is prohibited.

Authors

Date

2016

Department

Tieto- ja palvelutalouden laitos

Major/Subject

Mcode

Degree programme

Business Technology

Language

en

Pages

26

Series

Abstract

In this thesis, I explore how blockchain technology can improve pharmaceutical supply chain operations and discuss how the technology should be implemented. Furthermore, I study how the life science company Bayer's pharmaceutical division can utilize blockchain technology in its supply chain operations. I begin by defining the concepts of blockchain technology, smart contracts and pharmaceutical supply chain. Then I discuss the benefits and implementation in different sections: participating entities and information flow, contracts and payments, logistics, transparency and product security and blockchain infrastructure and governance. Both Bayer and the industry as a whole can benefit from blockchain technology. Blockchain enables for example efficient, safe and private transactions, product transparency and security and open information sharing without exposing trade secrets. For the first time a platform for all stakeholders can be developed that enables transacting information and value simultaneously.

Description

Thesis advisor

Wallenius, Jyrki

Keywords

blockchain, pharmaceuticals, supply chain, smart contract, Bayer

Other note

Citation

Permanent link to this item

https://urn.fi/URN:NBN:fi:aalto-201707046224

Collections

[kand] Kauppakorkeakoulu / BIZ (Open Access)